The most important question anyone should answer before any investment/trade is:
Is the a chance for an Asymmetrical payoff?
If your answer to this question is yes, then look at the other factors!
ARM: after early phase of decline moved +250%!
CRVW: is still a very young publicly traded company but its charts behaves like ARM at its early stages of public trading!
From fundamental point of view, its customers must increased exponentially if there will be an Ai boom!
(Skin in the game)
Is the a chance for an Asymmetrical payoff?
If your answer to this question is yes, then look at the other factors!
ARM: after early phase of decline moved +250%!
CRVW: is still a very young publicly traded company but its charts behaves like ARM at its early stages of public trading!
From fundamental point of view, its customers must increased exponentially if there will be an Ai boom!
(Skin in the game)
Nota
12% gain in 1 day!Nota
Nota
Let's have another update for the empty suits on this platform who think my content is illicit! Nota
Nota
Nota
The difference between a king who fights in front of the army and the empty suits who control content and set standards for it..! Nota
Nota
+88% in 2 wks Nota
Trade attivo
A simple question for empty suits: Who is the King? Trade chiuso: obiettivo raggiunto
Nota
Stock closed with 126.5% and option with 270% gainNota
Use the following link to access trading ideas: patreon.com/SniperTraderStocks?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
Use the following link to access trading ideas: patreon.com/SniperTraderStocks?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.